Individual and combined glucose-lowering effects of glucagon receptor antagonism and dipeptidyl peptidase-4 inhibition

被引：0
|
作者：
Maagensen, H. [1 ]
Haedersdal, S. [1 ]
Lund, A. [1 ]
Nielsen-Hannerup, E. [1 ]
Holst, J. [2 ]
Knop, F. [1 ,2 ]
Vilsboll, T. [3 ,4 ]
机构：
[1] Steno Diabet Ctr Copenhagen, Clin Metab Physiol, Hellerup, Denmark
[2] Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark
[3] Steno Diabet Ctr Copenhagen, Gentofte, Denmark
[4] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
504
引用
收藏
页码：S246 / S247
页数：2
相关论文
共 50 条
  • [41] Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
    Solerte, Sebastiano Bruno
    Di Sabatino, Antonio
    Galli, Massimo
    Fiorina, Paolo
    ACTA DIABETOLOGICA, 2020, 57 (07) : 779 - 783
  • [42] Dipeptidyl Peptidase-4 Inhibition May Stimulate Progression of Carcinoid Tumor
    Pech, Vladimir
    Abusaada, Khalid
    Alemany, Carlos
    CASE REPORTS IN ENDOCRINOLOGY, 2015, 2015
  • [43] Exendin-4 and dipeptidyl peptidase IV inhibitor isoleucine thiazolidide exert glucagon and glucose lowering effects in mouse models of diabetes
    Li, ZH
    Roy, RS
    Szalkowski, D
    Conarello, SL
    Jagpal, S
    Zhu, L
    Thornberry, NA
    Zhang, BB
    DIABETES, 2002, 51 : A341 - A341
  • [44] Glucose Lowering Treatment With Pioglitazone in Combination With Dipeptidyl Peptidase-4 Inhibitors (DPP4i) in Routine Clinical Practice
    Morgan, Christopher L. L.
    Puelles, Jorge
    Poole, Chris D.
    Lee, Chris
    Currie, Craig J.
    DIABETES, 2013, 62 : A665 - A665
  • [45] Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19
    Sebastiano Bruno Solerte
    Antonio Di Sabatino
    Massimo Galli
    Paolo Fiorina
    Acta Diabetologica, 2020, 57 : 779 - 783
  • [46] Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist
    Patel, Kershaw, V
    Sarraju, Ashish
    Neeland, Ian J.
    McGuire, Darren K.
    CURRENT CARDIOLOGY REPORTS, 2020, 22 (10)
  • [47] Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function
    Asuka Morita
    Eri Mukai
    Ayano Hiratsuka
    Tomozumi Takatani
    Toshihiko Iwanaga
    Eun Young Lee
    Takashi Miki
    Endocrine, 2016, 51 : 429 - 439
  • [48] Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: a Review for the General Cardiologist
    Kershaw V. Patel
    Ashish Sarraju
    Ian J. Neeland
    Darren K. McGuire
    Current Cardiology Reports, 2020, 22
  • [49] Mechanisms of Cardiovascular Injury in Type 2 Diabetes and Potential Effects of Dipeptidyl Peptidase-4 Inhibition
    Dokken, Betsy
    JOURNAL OF CARDIOVASCULAR NURSING, 2016, 31 (03) : 274 - 283
  • [50] Distinct effects of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist on islet morphology and function
    Morita, Asuka
    Mukai, Eri
    Hiratsuka, Ayano
    Takatani, Tomozumi
    Iwanaga, Toshihiko
    Lee, Eun Young
    Miki, Takashi
    ENDOCRINE, 2016, 51 (03) : 429 - 439
12345